NeoGenomics, Inc. Free Cash Flow 2010–2025
NeoGenomics, Inc. reported $-21.78M of free cash flow for fiscal 2025. That was 36.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +21.2%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $-21.78M | +36.0% |
| FY 2024 | $-34.04M | -10.9% |
| FY 2023 | $-30.70M | +68.3% |
| FY 2022 | $-96.88M | -6.6% |
| FY 2021 | $-90.86M | -228.8% |
| FY 2020 | $-27.64M | -927.4% |
| FY 2019 | $3.34M | -89.0% |
| FY 2018 | $30.48M | +601.1% |
| FY 2017 | $4.35M | -68.8% |
| FY 2016 | $13.94M | +233.7% |
| FY 2015 | $4.18M | -26.4% |
| FY 2014 | $5.68M | +2528.7% |
| FY 2013 | $216,000 | +107.0% |
| FY 2012 | $-3.11M | -275.2% |
| FY 2011 | $-828,000 | +72.1% |
| FY 2010 | $-2.97M | — |
Source: NeoGenomics, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open NEO 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
NeoGenomics, Inc. reported $-21.78M of free cash flow for fiscal 2025. That was 36.0% higher than fiscal 2024. Compared with fiscal 2020, the change was +21.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for NeoGenomics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeoGenomics, Inc. — frequently asked questions
What is NeoGenomics, Inc.'s free cash flow?
NeoGenomics, Inc. (NEO) reported free cash flow of $-21.78M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from NeoGenomics, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.